NCT04675476 A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
| NCT ID | NCT04675476 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgetown University |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 368 participants |
| Start Date | 2024-03-11 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 368 participants in total. It began in 2024-03-11 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Eligibility Criteria
Inclusion Criteria: * 50-80 years old; * current cigarette smoker or quit within 15 years; * a 20+ pack-year smoking history; * non-adherent to lung screening (\>13 months); * English-speaking; * scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and * able and willing to provide meaningful consent and complete telephone interviews Exclusion Criteria: * Individuals with a history of lung cancer
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04675476 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04675476 currently recruiting?
Yes, NCT04675476 is actively recruiting participants. Contact the research team at rmw27@georgetown.edu for enrollment information.
Where is the NCT04675476 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT04675476 clinical trial?
NCT04675476 is sponsored by Georgetown University. The trial plans to enroll 368 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.